
McKesson (MCK) Stock Forecast & Price Target
McKesson (MCK) Analyst Ratings
Bulls say
McKesson is well-positioned for growth in the US and Canadian pharmaceutical wholesale markets, as well as through medical-surgical supplies and technology solutions for pharmacies. With a strong focus on high-growth segments, diversification of services, and strategic partnerships, the company has the potential to continue generating strong financial results despite potential challenges in the healthcare industry. They also have a strong balance sheet and have actively repurchased shares to return value to shareholders.
Bears say
McKesson is facing several challenges in the near future, including regulatory changes in drug pricing and the growth of biosimilars. However, its strong infrastructure and focus on specialty pharma, as well as its plans to focus on higher-growth areas, may help mitigate these risks and contribute to potential growth for the company in the long term. The upside scenario presented in the article also suggests potential for increased profits and earnings for McKesson in the coming years.
This aggregate rating is based on analysts' research of McKesson and is not a guaranteed prediction by Public.com or investment advice.
McKesson (MCK) Analyst Forecast & Price Prediction
Start investing in McKesson (MCK)
Order type
Buy in
Order amount
Est. shares
0 shares